Prodeon Medical, Inc.

The Prodeon Medical, Inc. initiative was started in 2016 with the mission of transforming the approach to treating lower urinary tract symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH). The company has designed a promising new minimally-invasive and more patient-friendly approach to treating LUTS from BPH: the Prostatic Urethral REshaping procedure (PURE) using the investigational Urocross Expander System and Retrieval Sheath. The PURE procedure is conducted by way of standard flexible cystoscopic techniques, where the implant is removed leaving no permanent foreign body behind.